Biological markers and psychophysiological methods as long term response predictors to fluoxetine treatment

Journal of Affective Disorders

Volumn 80, Issue 2-3, 2004, Pages 291-292

  Fountoulakis, Konstantinos N ^a   Kaprinis, Stergios ^a   Iacovides, Apostolos ^a   Fotiou, Fotis ^a   Kaprinis, George ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BIOLOGICAL MARKER; DEXAMETHASONE; DEXFENFLURAMINE; DOPAMINE; FLUOXETINE; PROLACTIN; SEROTONIN; SEROTONIN RECEPTOR;

ADULT; ANALYSIS OF VARIANCE; ANALYTIC METHOD; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; DISEASE COURSE; DRUG RESPONSE; ELECTRORETINOGRAM; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; INFORMED CONSENT; LABORATORY TEST; LETTER; MELANCHOLIA; PREDICTION; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; RECURRENT DISEASE; REMISSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 2342636311     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(03)00104-6     Document Type: Editorial

References (3)

1. Loranger A.W., Sartorious N., Andreoli A., et al. The World Health Organisation/Alcohol, Drug Abuse and Mental Health Administration International Pilot Study of Personality Disorders. Arch Gen Psychiatry. 51:1994;215-224
2. O'Keane V., Dinan T.G. Prolactin and Cortisol Responses to d-Fenfluramine in Major Depression: Evidence for Diminished Responsivity of Central Serotonergic Function. Am. 1 Psychiatry. 148:1991;1009-1015
3. Wing J.K., Babor T., Brugha T., et al. SCAN: Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry. 47:1990;589-593